September 26, 2026

Treatment Innovations

Racing Against Time: Global Health Coalition Fast-Tracks Three Ebola Vaccines to Stem Outbreak in East Africa racing-against-time-global-health-coalition-fast-tracks-three-ebola-vaccines-to-stem-outbreak-in-east-africa

Racing Against Time: Global Health Coalition Fast-Tracks Three Ebola Vaccines to Stem Outbreak in East Africa

Suro Senen July 13, 2026
In an urgent move to curb the spread of the Bundibugyo ebolavirus (BDBV) in the Democratic Republic...
Read More Read more about Racing Against Time: Global Health Coalition Fast-Tracks Three Ebola Vaccines to Stem Outbreak in East Africa
Beyond Weight Loss: How Retatrutide is Redefining Metabolic Medicine and Cementing Lilly’s Market Dominance beyond-weight-loss-how-retatrutide-is-redefining-metabolic-medicine-and-cementing-lillys-market-dominance

Beyond Weight Loss: How Retatrutide is Redefining Metabolic Medicine and Cementing Lilly’s Market Dominance

Ammar Sabilarrohman July 12, 2026
The landscape of metabolic healthcare is undergoing a seismic shift. Eli Lilly and Company, currently the world’s...
Read More Read more about Beyond Weight Loss: How Retatrutide is Redefining Metabolic Medicine and Cementing Lilly’s Market Dominance
Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data revolutionizing-hit-id-ginkgo-tangible-and-inductive-bio-launch-adme-one-to-front-load-pharmacokinetic-data

Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data

Evan Lee Salim July 12, 2026
In the high-stakes arena of drug discovery, the timeline from a promising hit to a viable clinical...
Read More Read more about Revolutionizing Hit ID: Ginkgo, Tangible, and Inductive Bio Launch ADME-One to Front-Load Pharmacokinetic Data
The Commissioner’s National Priority Voucher (CNPV): A Regulatory Paradigm Shift or a High-Stakes Gamble? the-commissioners-national-priority-voucher-cnpv-a-regulatory-paradigm-shift-or-a-high-stakes-gamble

The Commissioner’s National Priority Voucher (CNPV): A Regulatory Paradigm Shift or a High-Stakes Gamble?

Asep Darmawan July 11, 2026
In June 2025, the U.S. Food and Drug Administration (FDA) unveiled the Commissioner’s National Priority Voucher (CNPV)...
Read More Read more about The Commissioner’s National Priority Voucher (CNPV): A Regulatory Paradigm Shift or a High-Stakes Gamble?
Roche Suffers Dual Setback in Huntington’s Disease Research, Dealing Blow to Pipeline Aspirations roche-suffers-dual-setback-in-huntingtons-disease-research-dealing-blow-to-pipeline-aspirations

Roche Suffers Dual Setback in Huntington’s Disease Research, Dealing Blow to Pipeline Aspirations

Nila Kartika Wati July 10, 2026
By [Your Name/Journalistic Staff] Published July 9, 2026 In a significant blow to the landscape of neurodegenerative...
Read More Read more about Roche Suffers Dual Setback in Huntington’s Disease Research, Dealing Blow to Pipeline Aspirations

You may have missed

biopharma-industry-update-novos-strategic-pivot-legal-victories-and-fda-approvals-reshape-the-landscape

Biopharma Industry Update: Novo’s Strategic Pivot, Legal Victories, and FDA Approvals Reshape the Landscape

Layla Zulfa September 26, 2026
navigating-the-post-pandemic-medicaid-landscape-a-comprehensive-review-of-enrollment-trends-and-unwinding-outcomes

Navigating the Post-Pandemic Medicaid Landscape: A Comprehensive Review of Enrollment Trends and Unwinding Outcomes

Siti Muinah September 26, 2026
the-architect-of-oncology-data-celebrating-the-legacy-and-leadership-of-lori-swain

The Architect of Oncology Data: Celebrating the Legacy and Leadership of Lori Swain

Siti Muinah September 26, 2026
bridging-the-policy-gap-metavivors-strategic-advocacy-for-the-metastatic-breast-cancer-community

Bridging the Policy Gap: METAvivor’s Strategic Advocacy for the Metastatic Breast Cancer Community

Lina Irawan September 26, 2026